A Multicenter, Randomized, Double-blind, Active-controlled Clinical Trial to Evaluate the Efficacy and Safety of a New Formulation of Zenon (Ezetimibe/Rosuvastatin Fixed Dose Combination) in Patients With Primary Hypercholesterolemia, Not Adequately Controlled on Statin Therapy

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 19 Aug 2019

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ezetimibe/rosuvastatin (Primary) ; Rosuvastatin
Indications Hypercholesterolaemia
Focus Registrational; Therapeutic Use
Acronyms ZENON
Sponsors Sanofi

Most Recent Events

17 Aug 2019 Planned End Date changed from 21 Oct 2019 to 6 Dec 2019.
13 Dec 2018 New trial record

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Welcome to AdisInsight